PENNY HEATON, M.D.
GLOBAL THERAPEUTIC AREA HEAD
INFECTIOUS DISEASES & VACCINES
JANSSEN RESEARCH & DEVELOPMENT, LLC
Penny Heaton, M.D., is the Global Therapeutic Area Head for Infectious Diseases & Vaccines at Janssen Research & Development, L.L.C. In this role, she leads a global team focused on developing transformational vaccines to prevent some of the most devastating infectious diseases the world faces today.
Penny holds two decades of vaccine research and development experience. She recently served as the Chief Executive Officer for the Bill & Melinda Gates Medical Research Institute (Gates MRI), where she led the development of investigational products from pre-clinical through late-stage development against multiple diseases including HIV, TB, malaria, pneumonia, enteric diseases, and polio. She has also led vaccine clinical research and development for companies including Novartis, Merck and Novavax. Notably, during her time at Meck, Penny co-developed a rotavirus vaccine which has been licensed in more than 100 countries and universally recommended by the World Health Organization for infants worldwide.
Penny began her career at the U.S. Centers for Disease Control and Prevention conducting diarrheal disease surveillance and investigating outbreaks of foodborne and diarrheal diseases, influencing her life-long passion for vaccine development.
A graduate of the University of Louisville School of Medicine in Kentucky, Penny is board-certified in Pediatrics and Pediatric Infectious Diseases. She is a member of the Pediatric Infectious Diseases Society and a fellow of the American Academy of Pediatrics.